SecBot SecBot
DEFA14A ·Filed Aug 19, 2026

TELO

Telomir Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001493152-26-039116
Proxy solicitation materials
Actionable Insight • Neutral

This filing is a routine administrative correction with no trading implications. Monitor the annual meeting outcome on September 11, 2026, for any material developments, but no immediate action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
TELO ▼ -4.27% at T+20d
NEUTRAL call -4.27% · α vs SPY -2.32% · entry $1.17 → $1.12
Next anchor: T+60d in 16d
Latest observation: T+46 +16.57% FF3 residual α
Entry = T+0 close
Aug 19, 2026
via day close
T+1d
-3.42%
call -3.42% · α -2.58%
$1.13
settled 2mo ago
T+5d
0.00%
call 0.00% · α +0.39%
$1.17
settled 2mo ago
T+20d
-4.27%
call -4.27% · α -2.32%
$1.12
settled 6w ago
T+60d
Pending
in 16d

Price Chart

Loading chart...

Executive Summary

Telomir Pharmaceuticals filed a DEFA14A supplement to its 2026 proxy statement, correcting the Audit Committee membership by adding Matthew Del Giudice. The filing is purely administrative and does not change any proposals or the upcoming annual meeting scheduled for September 11, 2026. No material financial or strategic impact.

Key Financial Metrics

Meeting
2026-09-11

Key Facts

  • Filing corrects Audit Committee membership to include Matthew Del Giudice alongside Matthew Whalen (Chair) and Edward MacPherson.
  • Supplement does not modify any proposals or the annual meeting date of September 11, 2026.
  • Original definitive proxy statement was filed on July 28, 2026.

Financial Impact

No financial impact — administrative correction only.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-039116
Document: 0001493152-26-039116-index-headers.html0001493152-26-039116
Document: 0001493152-26-039116-index.html0001493152-26-039116
Document: 0001493152-26-039116.txt0001493152-26-039116
9 reports for TELO
Performance horizon
Filters
Rows
Reports for TELO — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 5/10
$1.20awaiting T+20—$0.9990 (−16.75%)
Sep 17, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$1.12 $1.05▼ −6.25%▼ −7.46%$0.9990 (−10.80%)
Sep 17, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$1.12 $1.05▼ −6.25%▼ −7.71%$0.9990 (−10.80%)
Sep 14, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$1.17 $1.10▼ −5.98%▼ −8.25%$0.9990 (−14.62%)
Aug 19, 2026
9w ago
DEFA14A
NEUTRAL ★ 2/10
$1.17 $1.12▼ −4.27%▼ −2.32%$0.9990 (−14.62%)
Aug 10, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$1.17 $1.19▲ +1.71%▲ +2.62%$0.9990 (−14.62%)
Jun 15, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$1.29 $1.24▼ −3.88%▼ −3.13%$0.9990 (−22.56%)
Jun 8, 2026
20w ago
8-K
NEUTRAL ★ 2/10
$1.21 $1.24▲ +2.48%▲ +1.03%$0.9990 (−17.44%)
Apr 24, 2026
26w ago
8-K
MIXED ★ 7/10
$1.40 $1.30▼ −7.14%▼ −11.17%$0.9990 (−28.64%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 5h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026